Manual of Commercial Methods in Clinical Microbiology 2016
DOI: 10.1002/9781119021872.ch22
|View full text |Cite
|
Sign up to set email alerts
|

Automated and Manual Systems for Antimicrobial Susceptibility Testing of Bacteria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…An authenticated modified and verified cascaded series enrollments were dependent for establishing a net framework built-in design [8][9][10][11][12][13][14][15][16][17][18] in which two-hundred and twenty-five pooled samples were collected and verified from sectors of Al-Fudhaliyah, Al-Sadrya and Abu-Ghraib from January to March (2022). An authenticated, modified and verified cascaded series for isolation, identification and confirmation depended on this torment.…”
Section: Special Topics Built-in Designmentioning
confidence: 99%
“…An authenticated modified and verified cascaded series enrollments were dependent for establishing a net framework built-in design [8][9][10][11][12][13][14][15][16][17][18] in which two-hundred and twenty-five pooled samples were collected and verified from sectors of Al-Fudhaliyah, Al-Sadrya and Abu-Ghraib from January to March (2022). An authenticated, modified and verified cascaded series for isolation, identification and confirmation depended on this torment.…”
Section: Special Topics Built-in Designmentioning
confidence: 99%
“…Chromogenic substrates are also compatible with broth dilution methods, which are the core of many successful commercial AST platforms, such as the BD Phoenix system (BD; Franklin Lakes, NJ, USA), the MicroScan Walkaway system (Beckman-Coulter; Brea, CA, USA), the VITEK 2 System (BioMérieux), and the Sensititer system, (ThermoFisher Scientific; Waltham, MA, USA). These systems test colony isolate samples suspended in media to a 0.5 McFarland turbidity standard and test against CLSI, EUCAST or FDA standards over a period of 6–24 h through optical measurements of media turbidity and coloration . Reveal from Specific Diagnostics (Mountain View, CA, USA) is a small-molecule sensor array capable of colorimetric detection of volatile organic compounds produced by bacterial metabolic activity.…”
Section: Phenotypic Antimicrobial Susceptibility Testing For Antimicr...mentioning
confidence: 99%
“…These systems test colony isolate samples suspended in media to a 0.5 McFarland turbidity standard and test against CLSI, EUCAST or FDA standards over a period of 6−24 h through optical measurements of media turbidity and coloration. 32 Reveal from Specific Diagnostics (Mountain View, CA, USA) is a small-molecule sensor array capable of colorimetric detection of volatile organic compounds produced by bacterial metabolic activity. The array sheets are designed for use with 96-well broth microdilutions using colony isolates and produce SIR profiles within 5 h.…”
mentioning
confidence: 99%
“…This information is most important for physicians and prevents false negative results with yet unknown resistance genes [ 9 ]. To date, these systems require a preculture (16–24 h) of the patient samples [ 10 ]. In the field of microfluidics, many approaches have recently been taken to improve the accuracy and measurement speed of phenotypic ASTs [ 11 ].…”
Section: Introductionmentioning
confidence: 99%